189 related articles for article (PubMed ID: 8413409)
21. Outcome of modified St Jude total therapy 13A for childhood acute lymphoblastic leukemia in the southeast region of Turkey.
Koc A; Aycicek A; Ozdemir ZC; Soker M; Varma M
J Pediatr Hematol Oncol; 2013 Jan; 35(1):36-41. PubMed ID: 23138117
[TBL] [Abstract][Full Text] [Related]
22. Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children's hospital in China.
Gao YJ; Lu FJ; Wang HS
J Pediatr Hematol Oncol; 2006 Dec; 28(12):798-802. PubMed ID: 17164648
[TBL] [Abstract][Full Text] [Related]
23. Update of St Jude Study XI for childhood acute lymphoblastic leukemia.
Rivera GK; Pui CH; Hancock ML; Mahmoud H; Santana V; Sandlund JT; Hurwitz C; Ribeiro R; Furman W; Crist WM
Leukemia; 1992; 6 Suppl 2():153-6. PubMed ID: 1578920
[TBL] [Abstract][Full Text] [Related]
24. Long-term results of the Japanese Childhood Cancer and Leukemia Study Group studies 811, 841, 874 and 911 on childhood acute lymphoblastic leukemia.
Tsurusawa M; Shimomura Y; Asami K; Kikuta A; Watanabe A; Horikoshi Y; Matsushita T; Kanegane H; Ohta S; Iwai A; Mugishima H; Koizumi S;
Leukemia; 2010 Feb; 24(2):335-44. PubMed ID: 20016539
[TBL] [Abstract][Full Text] [Related]
25. Implementation of an intensive risk-stratified treatment protocol for children and adolescents with acute lymphoblastic leukemia in Lebanon.
Muwakkit S; Al-Aridi C; Samra A; Saab R; Mahfouz RA; Farra C; Jeha S; Abboud MR
Am J Hematol; 2012 Jul; 87(7):678-83. PubMed ID: 22565284
[TBL] [Abstract][Full Text] [Related]
26. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000.
Ribeiro RC; Razzouk BI; Pounds S; Hijiya N; Pui CH; Rubnitz JE
Leukemia; 2005 Dec; 19(12):2125-9. PubMed ID: 16281077
[TBL] [Abstract][Full Text] [Related]
27. Impact of three methods of treatment intensification on acute lymphoblastic leukemia in children: long-term results of St Jude total therapy study X.
Pui CH; Simone JV; Hancock ML; Evans WE; Williams DL; Bowman WP; Dahl GV; Dodge RK; Ochs J; Abromowitch M
Leukemia; 1992 Feb; 6(2):150-7. PubMed ID: 1552746
[TBL] [Abstract][Full Text] [Related]
28. Physical activity and late effects in childhood acute lymphoblastic leukemia long-term survivors.
Bertorello N; Manicone R; Galletto C; Barisone E; Fagioli F
Pediatr Hematol Oncol; 2011 Aug; 28(5):354-63. PubMed ID: 21413831
[TBL] [Abstract][Full Text] [Related]
29. Causes of death--other than progressive leukemia--in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience.
Slats AM; Egeler RM; van der Does-van den Berg A; Korbijn C; Hählen K; Kamps WA; Veerman AJ; Zwaan CM
Leukemia; 2005 Apr; 19(4):537-44. PubMed ID: 15690069
[TBL] [Abstract][Full Text] [Related]
30. Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
Gaynon PS; Bostrom BC; Hutchinson RJ; Lange BJ; Nachman JB; Steinherz PG; Sensel MG; Lee MK; Stram DO; Sather HN
J Clin Oncol; 2001 Apr; 19(7):1916-25. PubMed ID: 11283123
[TBL] [Abstract][Full Text] [Related]
31. Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.
Pui CH; Relling MV; Rivera GK; Hancock ML; Raimondi SC; Heslop HE; Santana VM; Ribeiro RC; Sandlund JT; Mahmoud HH
Leukemia; 1995 Dec; 9(12):1990-6. PubMed ID: 8609707
[TBL] [Abstract][Full Text] [Related]
32. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital.
Pui CH; Sandlund JT; Pei D; Campana D; Rivera GK; Ribeiro RC; Rubnitz JE; Razzouk BI; Howard SC; Hudson MM; Cheng C; Kun LE; Raimondi SC; Behm FG; Downing JR; Relling MV; Evans WE;
Blood; 2004 Nov; 104(9):2690-6. PubMed ID: 15251979
[TBL] [Abstract][Full Text] [Related]
33. St. Jude Total Therapy studies from I to XVII for childhood acute lymphoblastic leukemia: a brief review.
Omar AA; Basiouny L; Elnoby AS; Zaki A; Abouzid M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):25. PubMed ID: 35696003
[TBL] [Abstract][Full Text] [Related]
34. Pattern of mortality in childhood acute lymphoblastic leukemia: experience from a single center in northern India.
Marwaha RK; Kulkarni KP; Bansal D; Trehan A
J Pediatr Hematol Oncol; 2010 Jul; 32(5):366-9. PubMed ID: 20502353
[TBL] [Abstract][Full Text] [Related]
35. Transfusions and risk of failure in childhood acute lymphoblastic leukemia.
Freiberg AS; Hancock ML; Kunkel KD; Rivera GK; Crist WM
Leukemia; 1994 Jul; 8(7):1220-3. PubMed ID: 8035615
[TBL] [Abstract][Full Text] [Related]
36. Risk of adverse events in children completing treatment for acute lymphoblastic leukemia: St. Jude Total Therapy studies VIII, IX, and X.
Pui CH; Dodge RK; Look AT; George SL; Rivera GK; Abromowitch M; Ochs J; Evans WE; Crist WM; Simone JV
J Clin Oncol; 1991 Aug; 9(8):1341-7. PubMed ID: 2072137
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of Total Therapy Study XV for newly diagnosed childhood acute lymphoblastic leukemia.
Pui CH; Relling MV; Sandlund JT; Downing JR; Campana D; Evans WE
Ann Hematol; 2004; 83 Suppl 1():S124-6. PubMed ID: 15124703
[TBL] [Abstract][Full Text] [Related]
38. A strategy to improve treatment-related mortality and abandonment of therapy for childhood ALL in a developing country reveals the impact of treatment delays.
Suarez A; Piña M; Nichols-Vinueza DX; Lopera J; Rengifo L; Mesa M; Cardenas M; Morrissey L; Veintemilla G; Vizcaino M; Del Toro L; Vicuna V; Fernandez J; Neuberg D; Stevenson K; Gutierrez A
Pediatr Blood Cancer; 2015 Aug; 62(8):1395-402. PubMed ID: 25808195
[TBL] [Abstract][Full Text] [Related]
39. Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience.
Al-Nasser A; El-Solh H; De Vol E; El-Hassan I; Alzahrani A; Al-Sudairy R; Al-Mahr M; Al-Musa A; Al-Jefri A; Saleh M; Rifai S; Belgaumi A; Osman L; Ashraf K; Salim M; Silo A; Roberts G
Ann Saudi Med; 2008; 28(4):251-9. PubMed ID: 18596394
[TBL] [Abstract][Full Text] [Related]
40. Weekend delay in initiation of chemotherapy for acute lymphoblastic leukemia: does it matter?
Wahl SK; Gildengorin G; Feusner J
J Pediatr Hematol Oncol; 2012 Jan; 34(1):e8-e11. PubMed ID: 22146528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
